Active ingredientSalmeterolCat. No. P-S010-001CAS 89365-50-4Family · Pharmaceutical analytical standards
Salmeterol
A long-acting beta-2 agonist bronchodilator, patented in 1983 and in use since 1990: it is inhaled to control the symptoms of asthma, together with a corticosteroid, and of chronic obstructive pulmonary disease (COPD). This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?The secret of its duration, about 12 hours against 4-6 for salbutamol, is a long lipophilic side chain: it dissolves in the cell membrane and feeds the receptor a little at a time.
Go to the active ingredient →Active ingredientSalmeterolCat. No. P-S010-001CAS 89365-50-4
Active ingredientSalmeterol XinafoateCat. No. P-S010-002CAS 94749-08-3
Pharmacopoeial impuritySalmeterol EP Impurity ACat. No. P-S010-003CAS 1798014-51-3
Pharmacopoeial impuritySalmeterol EP Impurity BCat. No. P-S010-004CAS 94749-02-7
Pharmacopoeial impuritySalmeterol EP Impurity CCat. No. P-S010-005CAS 94749-11-8
Pharmacopoeial impuritySalmeterol EP Impurity DCat. No. P-S010-006CAS 1391052-04-2
Pharmacopoeial impuritySalmeterol EP Impurity ECat. No. P-S010-007CAS 108928-81-0
Pharmacopoeial impuritySalmeterol EP Impurity FCat. No. P-S010-008CAS 1391054-40-2
Pharmacopoeial impuritySalmeterol EP Impurity GCat. No. P-S010-009CAS 2470130-36-8
Isotopically labelledSalmeterol-d3Cat. No. P-S010-010CAS 497063-94-2
NitrosamineN-Nitroso SalmeterolCat. No. P-S010-011
ImpuritySalmeterol Impurity 1Cat. No. P-S010-012CAS 160889-18-9
Impurity4-(2-bromophenyl)butan-1-olCat. No. P-S010-013CAS 123206-83-7
Impurity4-(3-bromophenyl)butan-1-olCat. No. P-S010-014CAS 218153-01-6
Impurity4-(4-bromophenyl)butan-1-olCat. No. P-S010-015CAS 75906-36-4![4-[(6-Bromohexyl)oxy]butylbenzene](https://img.vitasanlabs.com/vsl-struct/P-S010-016.svg?v=41e934f030)
Impurity4-[(6-Bromohexyl)oxy]butylbenzeneCat. No. P-S010-016CAS 94749-73-2
Impurity4-Phenyl-1-butanolCat. No. P-S010-017CAS 3360-41-6
Impurity6-(4-phenylbutoxy)hexan-1-amineCat. No. P-S010-018CAS 97664-58-9
ImpurityMethyl 3-acetyl-4-(benzyloxy)benzoateCat. No. P-S010-019CAS 65843-60-9
ImpuritySalmeterol Impurity 2Cat. No. P-S010-020CAS 27475-14-5
ImpuritySalmeterol Hydroxynaphthoic Acid ImpurityCat. No. P-S010-021CAS 86-48-6
ImpuritySalmeterol Impurity 3 HydrochlorideCat. No. P-S010-022CAS 144391-74-2
ImpuritySalmeterol Impurity 4Cat. No. P-S010-023
ImpuritySalmeterol Impurity 5Cat. No. P-S010-024
ImpuritySalmeterol Impurity 6Cat. No. P-S010-025
ImpuritySalmeterol Impurity 7Cat. No. P-S010-026CAS 452339-72-9
ImpuritySalmeterol Impurity 8Cat. No. P-S010-027CAS 2724154-01-0
ImpuritySalmeterol Impurity 9Cat. No. P-S010-028
ImpuritySalmeterol Impurity 10Cat. No. P-S010-029
ImpuritySalmeterol Impurity 11Cat. No. P-S010-030
ImpuritySalmeterol Impurity 12Cat. No. P-S010-031
ImpuritySalmeterol Impurity HCat. No. P-S010-032CAS 1330076-52-2No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceSalmeterol xinafoate CRSEDQM code Y0000422Family SalmeterolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.